STAA PE Ratio & Valuation, Is STAA Overvalued

Historical Valuation

STAAR Surgical Co (STAA) is now in the Overvalued zone, suggesting that its current forward PE ratio of 136.99 is considered Overvalued compared with the five-year average of 63.17. The fair price of STAAR Surgical Co (STAA) is between 8.82 to 26.73 according to relative valuation method. Compared to the current price of 29.89 USD , STAAR Surgical Co By Overvalued By 11.83%.

Relative Value

Fair Zone

8.82-26.73

Current Price：29.89

11.83%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is STAAR Surgical Co (STAA) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

STAAR Surgical Co (STAA) has a current Price-to-Book (P/B) ratio of 4.44. Compared to its 3-year average P/B ratio of 4.03, the current P/B ratio is approximately 10.00% higher. Relative to its 5-year average P/B ratio of 8.65, the current P/B ratio is about -48.74% higher. STAAR Surgical Co (STAA) has a Forward Free Cash Flow (FCF) yield of approximately -3.52%. Compared to its 3-year average FCF yield of -1.18%, the current FCF yield is approximately 199.13% lower. Relative to its 5-year average FCF yield of -0.44%, the current FCF yield is about 700.03% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for STAA competitors is 25.55, providing a benchmark for relative valuation. STAAR Surgical Co Corp (STAA.O) exhibits a P/S ratio of 4.34, which is -83% above the industry average. Given its robust revenue growth of 119.59%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of STAA increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of STAA in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is STAA currently overvalued or undervalued?

What is STAAR Surgical Co (STAA) fair value?

STAA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of STAAR Surgical Co (STAA) is between 8.82 to 26.73 according to relative valuation method.

How does STAA's valuation metrics compare to the industry average?

The average P/S ratio for STAA's competitors is 25.55, providing a benchmark for relative valuation. STAAR Surgical Co Corp (STAA) exhibits a P/S ratio of 4.34, which is -83.00% above the industry average. Given its robust revenue growth of 119.59%, this premium appears sustainable.

What is the current P/B ratio for STAAR Surgical Co (STAA) as of May 30 2026?

As of May 30 2026, STAAR Surgical Co (STAA) has a P/B ratio of 4.44. This indicates that the market values STAA at 4.44 times its book value.

What is the current FCF Yield for STAAR Surgical Co (STAA) as of May 30 2026?

As of May 30 2026, STAAR Surgical Co (STAA) has a FCF Yield of -3.52%. This means that for every dollar of STAAR Surgical Co's market capitalization, the company generates -3.52 cents in free cash flow.

What is the current Forward P/E ratio for STAAR Surgical Co (STAA) as of May 30 2026?

As of May 30 2026, STAAR Surgical Co (STAA) has a Forward P/E ratio of 136.99. This means the market is willing to pay $136.99 for every dollar of STAAR Surgical Co's expected earnings over the next 12 months.

What is the current Forward P/S ratio for STAAR Surgical Co (STAA) as of May 30 2026?

As of May 30 2026, STAAR Surgical Co (STAA) has a Forward P/S ratio of 4.34. This means the market is valuing STAA at $4.34 for every dollar of expected revenue over the next 12 months.

STAA Valuation